Legislative UpdatesUpdate on ASKP3 Activities in TexasOver the past several months, the American Society of Ketamine Physicians, Psychotherapists Over the past several months, Texas has become a critical focal point for the future of ketamine therapy regulations, with implications that could shape the national landscape. As one of the largest and most influential medical boards in the country, the Texas Medical Board’s (TMB) actions set precedents that resonate far beyond state lines. The work ASKP3 is undertaking in Texas not only ensures the safe and effective use of ketamine for psychiatric conditions but also establishes a model for collaboration and innovation that can inspire similar efforts nationwide. By actively engaging with lawmakers, regulatory authorities, and diverse stakeholders, ASKP3 is leading the charge in creating a framework that balances patient safety, accessibility, and professional oversight—paving the way for the future of ketamine therapy across the United States. December 2024: Click here for more information and to view the full update [member log-in required.] |